Clinical Trials Sponsored by Regione Veneto

Total 3699 results

Istituto Oncologico Veneto IRCCS
Regione del Veneto (Italy)

Active, not recruiting

Risk-Based Breast Screening in Young Women (RIBBS)

Breast Neoplasms

Italy
University of Padova
IL Sogno di Stefano; Regione Veneto

Unknown

Evaluation of the Effectiveness of Antibiotic Prophylaxis in Children With a Previous Urinary Tract Infection

Urinary Tract Infections

Italy
University of Padova
IL Sogno di Stefano; Regione Veneto

Terminated

Oral vs Initial Intravenous Antibiotic Treatment of Urinary Tract Infections in Children: a RCT

Urinary Tract Infections
Regione Veneto
European Commission; Azienda ULSS 4 Alto Vicentino

Completed

Life-Long Monitoring of Diabetes Mellitus in Veneto Region

Diabetes Mellitus, Type 2

Italy
Azienda Ospedaliera di Padova
University of Padova; Regione Veneto

Completed

Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.

Hepatitis C Virus | Chronic Liver Disease | Therapeutic Uses | Viral Hepatitis | Antiviral Agents

Italy
University of Padova
Mirano's Hospital, Mirano, Italy; San Giacomo Apostolo Hospital, Castelfranco... and other collaborators

Completed

Safety Study to Assess the FEasibility of Use of the TRYTON Bifurcation Coronary Stent System (SAFE-TRY) (SAFE-TRY)

Coronary Artery Disease | Angioplasty, Transluminal, Percutaneous Coronary

Italy
Istituto Oncologico Veneto IRCCS

Recruiting

OLIGOS: Impact of Treatment on Primary Tumour in Patients With Newly Diagnosed Oligometastatic Neoplasia of the Prostate (OLIGOS)

Oligometastatic Prostate Carcinoma

Italy
Istituto Oncologico Veneto IRCCS

Active, not recruiting

Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma (ZEBRA)

Renal Cell Carcinoma

Italy
Istituto Oncologico Veneto IRCCS

Completed

Epidemiological Features and Clinical Course of COVID -19 Infection in Cancer Patients: The Rovid Study

Solid Tumor, Adult

Italy
Istituto Oncologico Veneto IRCCS

Recruiting

ImmunoNutrition and Colorectal Adenocarcinoma Surgery - INCAS Study (INCAS)

Colorectal Adenocarcinoma

Italy
Istituto Oncologico Veneto IRCCS

Recruiting

Pure Florid and Pleomorphic Lobular Carcinoma in Situ of the Breast: Towards an Increasingly Uniform Management

Pleomorphic Lobular Breast Carcinoma in Situ | Breast Florid Lobular Carcinoma in Situ

Italy
Istituto Oncologico Veneto IRCCS

Completed

Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS

Glioblastoma Multiforme

Italy
Istituto Oncologico Veneto IRCCS

Active, not recruiting

First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer (COBRA)

Elderly Metastatic Colorectal Cancer Patients

Italy
Istituto Oncologico Veneto IRCCS

Completed

CAlorie and Protein REstriction PROgram in Barrett's Esophagus Patients (CARE-PRO). (CARE-PRO)

Overweight and Obesity | Barrett's Esophagus
Istituto Oncologico Veneto IRCCS

Terminated

TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES) (TIMES)

Carcinoma, Small Cell

Italy
Istituto Oncologico Veneto IRCCS

Active, not recruiting

First Line Osimertinib in the Real World: an Inter-regional Prospective Study (FLOWER)

EGF-R Positive Non-Small Cell Lung Cancer

Italy
Istituto Oncologico Veneto IRCCS

Completed

Videoscopic Ilioinguinal Lymphadenectomy for Melanoma

Melanoma | Secondary Malignant Neoplasm of Lymph Node
Istituto Oncologico Veneto IRCCS

Completed

Psychological Counselling in Diagnostic Screening

Cancer
Istituto Oncologico Veneto IRCCS
Bayer

Not yet recruiting

Regorafenib for Recurrent Grade 2 and 3 Meningioma (MIRAGE Trial) (MIRAGE)

Meningioma, Malignant

Italy
Istituto Oncologico Veneto IRCCS
Azienda Ulss 2 Marca Trevigiana; Azienda ULSS 3 Serenissima; Regione Veneto; Azienda... and other collaborators

Completed

Conservative Management of CIN2 Lesions and Biomarkers Evaluation

CIN2

Italy
Istituto Oncologico Veneto IRCCS
Bayer S.p.A

Recruiting

Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients (REGOMA-2)

Glioblastoma, IDH-wildtype | MGMT-Methylated Glioblastoma

Italy
Istituto Oncologico Veneto IRCCS
Indena S.p.A

Completed

Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer Patients (ROSAM)

Oral Mucositis | Head-and-neck Squamous Cell Carcinoma

Italy
Veniti

Withdrawn

VERITAS: An Evaluation of the Veniti Vidi Retrievable Inferior Vena Cava Filter System in Patients at Risk for Pulmonary Embolism (VERITAS)

Deep Vein Thrombosis | Pulmonary Embolus

New Zealand, Australia
Istituto Oncologico Veneto IRCCS
University of Padova

Completed

Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer Patients (MAIN-A)

Breast Cancer Metastatic

Italy
Istituto Oncologico Veneto IRCCS
Fondazione Guido Berlucchi

Completed

Totally Implantable Venous Access Devices: Quality of Life and Body Image (BI-PORT)

Neoplasms Undergoing Chemotherapy

Italy
Istituto Oncologico Veneto IRCCS
MSD Italia S.r.l.

Not yet recruiting

Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study) (CHIMERA)

Pleural Mesothelioma

Italy
Istituto Oncologico Veneto IRCCS
Roche Pharma AG

Active, not recruiting

The GOLD Study: G8 in OLDer Patients (GOLD)

Elderly Metastatic Colorectal Cancer Patients

Italy
Istituto Oncologico Veneto IRCCS
BAYER S.p.A. - Italia

Completed

Regorafenib in Relapsed Glioblastoma (REGOMA)

Glioblastoma Multiforme

Italy
Istituto Oncologico Veneto IRCCS
University of Padova

Completed

Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients (GIADA)

Breast Cancer

Italy
Istituto Oncologico Veneto IRCCS
Janssen Diagnostics, LLC

Unknown

Circulating Melanoma Cells in Metastatic Patients Treated With Selective BRAF Inhibitors (CMCBRAF)

Metastatic Melanoma

Italy
Istituto Oncologico Veneto IRCCS
Fidia Farmaceutici s.p.a.

Not yet recruiting

A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer (Hydeal Cyst)

Non-muscle Invasive Bladder Cancer

Italy
Azienda Sanitaria Ospedaliera
Istituto Oncologico Veneto IRCCS

Recruiting

LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA) (LITALHICA)

Perihilar Cholangiocarcinoma

Italy
Azienda Sanitaria Ospedaliera
Istituto Oncologico Veneto IRCCS

Recruiting

LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma (LIRICA) (LIRICA)

Intrahepatic Cholangiocarcinoma

Italy
Hospital Moinhos de Vento

Recruiting

Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian Population

Prostate Cancer

Brazil
Hospital Moinhos de Vento

Terminated

Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections (OPTIMISE)

Sepsis | Gram-Negative Bacterial Infections | Bacteremia | Severe Infection | Bloodstream Infection | Acinetobacter Infections | Pseudomonas Aeruginosa | Human | Carbapenem-Resistant Enterobacteriaceae Infection | Carbapenem Resistant Bacterial Infection

Brazil
Hospital Moinhos de Vento

Active, not recruiting

Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Mild COVID-19 Patients in Brazil

COVID-19 | Quality of Life | Disability Physical | Disabilities Mental

Brazil
Hospital Moinhos de Vento

Not yet recruiting

Evaluation of the Impact of Telemedicine in Pediatric Intensive Care Units

Adolescent | Telemedicine | Critical Care | Pediatric | Intensive Care Units, Pediatric
Hospital Moinhos de Vento

Not yet recruiting

Interventions for Enhancing Adherence to Syphilis Treatment and Follow-up: Study Protocol for the Health Information and Monitoring of Sexually Transmitted Infections (SIM) Randomized Controlled Trial (SIM)

Syphilis
Hospital Moinhos de Vento

Active, not recruiting

Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Moderate and Severe COVID-19 Patients in Brazil

COVID-19 | Quality of Life | Disability Physical | Disabilities Mental

Brazil
Hospital Moinhos de Vento

Completed

Orientation Effects of Breastfeeding for Mothers

Breastfeeding

Brazil
Hospital Moinhos de Vento

Unknown

Pharmaceutical Care in Ambulatory Hemodialysis Patients

Medication Adherence | Renal Failure Chronic Requiring Hemodialysis | Chronic Renal Diseases

Brazil
Hospital Moinhos de Vento

Recruiting

Protocol For Sleep for Critically Ill Patients

Sleep Disorders

Brazil
Hospital Moinhos de Vento

Recruiting

Deflating the Tracheostomy Tube Cuff and Time for Decannulation

Deglutition Disorders | Tracheostomy Complication

Brazil
Hospital Moinhos de Vento

Not yet recruiting

Long-term Impact of COVID-19 Among COVID-19 Patients With Acute Respiratory Distress Syndrome in Brazil

COVID-19 | ARDS
Hospital Moinhos de Vento

Completed

Clinical Trial Comparing Carnoy's and GEWF Solutions

Colorectal Cancer | Lymph Node Metastasis

Brazil
Hospital Moinhos de Vento

Unknown

The Effects of Mechanical Insufflation-exsufflation on Airway Mucus Clearance in the ICU

Respiratory Failure

Brazil
Hospital Moinhos de Vento

Completed

Glycemic Index Variation During Low-carbohydrate Enteral Formula With and Without Fructose in Critically Ill Patients

Critical Illness
Hospital Moinhos de Vento

Completed

Role of Lung Ultrasound in Predicting Weaning Outcomes

Ultrasonography | Ventilator Weaning

Brazil
Ventor Technologies

Unknown

Transapical Implantation of Ventor Embracer™ Valve in Patients With Severe Aortic Valve Disease

Aortic Valve Disease

Germany
Azienda Ospedaliera di Padova
Istituto Oncologico Veneto IRCCS

Recruiting

Colorectal Metastasis and Liver Transplantation With Organs From Deceased Donors (MELODIC)

Colorectal Adenocarcinoma | Colorectal Liver Metastases | Unresectable Malignant Neoplasm

Italy

Clinical Trials Sponsored by Regione Veneto

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations